Mizuho Securities Remains Sidelined on Diplomat Pharmacy (DPLO) Following 4Q
Tweet Send to a Friend
Mizuho Securities reiterated a Neutral rating and $17.00 price target on Diplomat Pharmacy (NYSE: DPLO) following the company's 4Q earnings ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
